Can a groundbreaking cancer therapy help people with multiple sclerosis?
Lead: A small, early-stage trial at the Cleveland Clinic is testing whether CAR-T — a cancer immunotherapy that reprograms a patient’s T cells — can curb multiple sclerosis (MS) by eliminating overactive B cells. The trial enrolled four people with MS and began infusions between six and 12 months ago; participant Grace Miller received her … Read more